Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus

By sjmartinez • March 15, 2025

Zhang Y, Tedeschi SK, Abhishek A, Hensey O, Grossberg D, Cai K, Shea B, Singh JA, Christensen R, Serban T, Cipolletta E, Parperis K, Diaz-Torne C, McCarthy GM, Becce F, Gheita TA, Sirotti S, Christiansen SN, Coronel L, Stamp LK, Abdel-Fattah YH, Pascart T, Filippou G, Hong LE, FitzGerald J, Dalbeth N. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Mar 7;72:152669. doi: 10.1016/j.semarthrit.2025.152669. Epub ahead of print. PMID: 40086154.

Tags: calcium pyrophosphate deposition disease, Core domain set, Delphi, Domain, OMERACT, Publications, Rheumatology, Veterans Administration

Racial and Ethnic Disparities in Diabetes Prevention Outcomes: Insights from the Prediabetes Informed Decisions and Education Study

Castellon-Lopez Y, Duru OK, Turk N, Moreno G, Norris KC, Vu A, Saju RP, Tseng CH, Skrine-Jeffers K, Mangione CM, Frosch D, Moin T. Racial[...]

Reply to Currow et al.: Geographic Variation in Prevalence of Breathlessness: Latitude

Suri R, Tashkin DP, Buhr RG, Barjaktarevic I. Reply to Currow et al.: Geographic Variation in Prevalence of Breathlessness: Latitude. Am J Respir Crit Care Med.[...]

The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi[...]